Michael A. Zompa

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 1: Introduction and Process Overview

Wenjun Liu, Sachin Lohani, Hong Ren, 2020 .

Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines

Richard G. Moore, Michael A. Zompa, C. Seto, 2012, Investigational New Drugs.

Nucleolar binding of an anti-NMDA receptor antibody in hydra: a non-canonical role for an NMDA receptor protein?

Michael A. Zompa, G. Kass-simon, A. Scappaticci, 2009, Journal of experimental zoology. Part A, Ecological genetics and physiology.

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 3: Development of a One-Pot Formylation–Cyclization Sequence to the Diaminopyrimidine Core

Nicholas J. Rogus, Rebecca A. Arvary, Michael A. Zompa, 2020 .

Manufacturing Process Development for Uprifosbuvir (MK-3682): A Green and Sustainable Process for Preparing Penultimate 2′-Deoxy-α-2′-Chloro-β-2′-Methyluridine

Michael A. Zompa, Rebecca T. Ruck, George Zhou, 2022, Organic Process Research & Development.

Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19

Michael A. Zompa, E. Sirota, L. Tan, 2021, Organic process research & development.

Cis-regulatory organization of the Pax6 gene in the ascidian Ciona intestinalis.

Michael A. Zompa, S. Irvine, Rajee Antony, 2008, Developmental biology.